Karin Brecht
Impact in
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac electrophysiology and arrhythmias
Papers in
-
- Pharmacogenetics and Drug Metabolism 3
-
- Antiplatelet Therapy and Cardiovascular Diseases 4
- Cardiac electrophysiology and arrhythmias 2
- Co-authors
- Stephan Krähenbühl (10 shared papers)Anja Zahno (5 shared papers)Michael Török (3 shared papers)K. Waldhauser (3 shared papers)Stephan Krähenbühl (3 shared papers)Priska Kaufmann (1 shared paper)Peter W. Lindinger (3 shared papers)Peter Mullen (2 shared papers)
- Journals
- APOPTOSIS (2 papers)Toxicology (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Biochemical Pharmacology (2 papers)British Journal of Pharmacology (2 papers)
- Partner nations
- SwitzerlandGermanyAustria
In The Last Decade
Karin Brecht
25 papers receiving 880 citations
Peers
Comparison fields: 5 of 95
- Pharmacology 139
- Cardiology and Cardiovascular Medicine 155
- Cancer Research 85
- Clinical Biochemistry 40
- Molecular Biology 392
Countries citing papers authored by Karin Brecht
This map shows the geographic impact of Karin Brecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Brecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Brecht more than expected).
Fields of papers citing papers by Karin Brecht
This network shows the impact of papers produced by Karin Brecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Brecht. The network helps show where Karin Brecht may publish in the future.
Co-authors
The 25 scholars most cited alongside Karin Brecht, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 218 | |
| 2 | 2006 | 106 | |
| 3 | 2010 | 103 | |
| 4 | 2009 | 71 | |
| 5 | 2011 | 66 | |
| 6 | 2005 | 49 | |
| 7 | 2010 | 47 | |
| 8 | 2002 | 30 | |
| 9 | 2016 | 27 | |
| 10 | 2013 | 26 | |
| 11 | 2020 | 26 | |
| 12 | 2008 | 25 | |
| 13 | 2012 | 24 | |
| 14 | 2016 | 19 | |
| 15 | 2013 | 18 | |
| 16 | 2005 | 12 | |
| 17 | The response of isolated arteries and veins to potassium, osmolarity and drugs. | 1969 | 12 |
| 18 | 2019 | 9 | |
| 19 | 2023 | 8 | |
| 20 | 2005 | 7 |
About Karin Brecht
Karin Brecht is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine, Biochemistry, Molecular Biology and Oncology, having authored 25 papers that have together received 916 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Cell death mechanisms and regulation (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Cardiac electrophysiology and arrhythmias (2 papers), Amino Acid Enzymes and Metabolism (2 papers), Mitochondrial Function and Pathology (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Pharmacology (139 citations), Cardiology and Cardiovascular Medicine (155 citations), Cancer Research (85 citations), Clinical Biochemistry (40 citations) and Molecular Biology (392 citations). Karin Brecht has collaborated with scholars based in Switzerland, Germany and Austria. Frequent co-authors include Stephan Krähenbühl, Anja Zahno, Michael Török, K. Waldhauser, Stephan Krähenbühl, Priska Kaufmann, Peter W. Lindinger, Peter Mullen, Daniel Konrad and Hubert Scharnagl. Their work appears in journals such as APOPTOSIS, Toxicology, Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.